Revolution Medicines and Moderna prove that high-risk bets on undruggable targets can finally work - here's what it means for biotech investors and pharma execs.

Robert Kiyosaki says he owes US$1.2 billion; in China, burned property investors are wrestling with awe and bitterness.

Millennial nostalgia and global capital have turned rare Pokemon cards into a serious investment, complete with grading, tokenization, and even crime.

The company also boosted its own math scores and cut Anthropic's, raising questions about 'benchmaxxing' in AI evaluation.

After Xbox divested Double Fine, founder Tim Schafer reveals how he fought to keep the studio alive and independent.

In a letter to customers, GoPro's CEO promises the business keeps its 'core DNA,' yet the deal is being framed around national security and the largest individual shareholder gets no mention.

A stronger-than-expected August jobs report just pushed Citigroup's expected Fed rate cuts back by months. Here's what that means for your borrowing costs.

The smart ring maker’s rise reflects a broader shift toward wearable health tracking, with implications for employers, insurers, and the future of preventive care.

The next-gen robotaxi's first public rule is an adult-only age floor, and it rewrites the near-term family-use case for autonomous transit.

As Ukraine sells millions of drone data points to defense and AI companies, a former Biden White House researcher warns the front line is becoming a model training site that demands regulation.

The end-of-February Iran conflict is driving wholesale oil costs up, and diesel at the pump is paying the price. Here's why it matters for every CFO and fleet operator.

Small card businesses are losing thousands to mail-order theft, forcing new packaging, insurance, and delivery strategies.